These results provided proof-of-concept support for using TRPM8 channel-targeting nanotechnologies based on LNC to develop more effective methods for inhibiting prostate cancer cell migration in vivo and to explore the modulation of additional channels because several TRPs are implicated in different types of cancers45,46. Here, TRPM8 is linked to Familial prostate cancer.